Evidence map›Paper›PMID 25749641›Full record

Trial reportRespiratory medicine2015

Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis.

Courtney M Wheatley, Sarah E Baker, Mary A Morgan, Marina G Martinez, Wayne J Morgan, Eric C Wong, Stephen R Karpen, Eric M Snyder

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Respiratory medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Physical activity and exercise training in cystic fibrosis.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Physical exercise training for cystic fibrosis.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Courtney M WheatleyDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: wheatley.courtney@mayo.edu.
Sarah E BakerDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA; Department of Kinesiology, University of Minnesota, Minneapolis, MN, USA. Electronic address: land0376@umn.edu.
Mary A MorganDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: uagrad06@gmail.com.
Marina G MartinezDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: mgm2@email.arizona.edu.
Wayne J MorganDepartment of Pediatrics- Pulmonology, Allergy and Immunology, University of Arizona, Tucson, AZ, USA. Electronic address: wjmorgan@arc.arizona.edu.
Eric C WongDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: ecwong47@gmail.com.
Stephen R KarpenDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: karpen@pharmacy.arizona.edu.
Eric M SnyderDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA; Department of Kinesiology, University of Minnesota, Minneapolis, MN, USA. Electronic address: snyd0180@umn.edu.
University of Arizona · USUniversity of Minnesota · USMayo Clinic in Arizona · US

Funding

Gene-by-Gene Interactions and Lung Fluid Balance in Patients with Heart FailureR01HL108962 · NHLBI · UNIVERSITY OF MINNESOTA · PI SNYDER, ERIC M · 2011 to 2016
$2.2M
NHLBI NIH HHS HL108962-01NHLBI NIH HHS R01 HL108962
6 · The paper itself

Abstract

backgroundAlthough exercise is a vital component of the therapy prescribed to individuals with cystic fibrosis (CF), it is not a priority due to a finite amount of treatment time and the view that exercise is not as beneficial as pharmacological treatments by many individuals with CF. We sought to compare the therapeutic benefits of exercise and their prescribed bronchodilator albuterol.

methodsCF (n = 14) and healthy (n = 16) subjects completed three visits, a baseline screening with VO2 max test and two treatment visits. On the two treatment visits, subjects completed spirometry and diffusing capacity of the lungs for nitric oxide (DLNO) maneuvers either at baseline, 60, and 110 min post-albuterol administration, or at baseline and the midway point of three separate 15 min exercise bouts at low, moderate and vigorous intensity (25, 50 and 65% of the maximum workload, respectively).

resultsWith moderate exercise the increase in DLNO was double (39 ± 8 vs 15  ± 6% change) and the level of bronchodilation similar (23% change) when compared to 110 min post-albuterol in individuals with CF. During exercise FVC became reduced (-309 ± 66 mL with moderate exercise) and the increase in FEV1 was attenuated (103 ± 39 vs 236 ± 58 mL, exercise vs. albuterol) when compared with the response to albuterol in individuals with CF. Epinephrine (EPI) release increased 39, 72 and 144% change with low, moderate and vigorous intensity exercise respectively for individuals with CF, but this increase was blunted when compared to healthy subjects.

conclusionOur results suggest that moderate intensity exercise is the optimal intensity for individuals with CF, as low intensity exercise increases EPI less than 50% and vigorous intensity exercise is over taxing, such that airflow can be restricted. Although the duration of the beneficial effect is uncertain, exercise can promote greater improvements in gas diffusion and comparable bronchodilation when compared to albuterol.

Indexed as

Cystic FibrosisAdolescentAdultAlbuterolBlood Gas AnalysisBreathing ExercisesBronchodilator AgentsCross-Over StudiesExercise TestExercise TherapyExercise ToleranceFacilitated DiffusionFemaleHumansMaleNitric OxideAlbuterolBronchodilator AgentsNitric OxideAlbuterolBronchodilationCatecholaminesCycle ergometerDiffusion capacity of the lungs for nitric oxideSubmaximal exercise

Identifiers

PMID25749641
PMCPMC5963531
OpenAlexW1998757550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.